Co-Administration of Nanowired Monoclonal Antibodies to Inducible Nitric Oxide Synthase and Tumor Necrosis Factor Alpha Together with Antioxidant H-290/51 Reduces SiO2 Nanoparticles-Induced Exacerbation of Pathophysiology of Spinal Cord Trauma
- PMID: 37480462
- DOI: 10.1007/978-3-031-32997-5_5
Co-Administration of Nanowired Monoclonal Antibodies to Inducible Nitric Oxide Synthase and Tumor Necrosis Factor Alpha Together with Antioxidant H-290/51 Reduces SiO2 Nanoparticles-Induced Exacerbation of Pathophysiology of Spinal Cord Trauma
Abstract
Military personnel are often exposed to silica dust during combat operations across the globe. Exposure to silica dust in US military or service personnel could cause Desert Strom Pneumonitis also referred to as Al Eskan disease causing several organs damage and precipitate autoimmune dysfunction. However, the effects of microfine particles of sand inhalation-induced brain damage on the pathophysiology of traumatic brain or spinal cord injury are not explored. Previously intoxication of silica nanoparticles (50-60 nm size) is shown to exacerbates spinal cord injury induces blood-spinal cord barrier breakdown, edema formation and cellular changes. However, the mechanism of silica nanoparticles-induced cord pathology is still not well known. Spinal cord injury is well known to alter serotonin (5-hydroxytryptamine) metabolism and induce oxidative stress including upregulation of nitric oxide synthase and tumor necrosis factor alpha. This suggests that these agents are involved in the pathophysiology of spinal cord injury. In this review, we examined the effects of combined nanowired delivery of monoclonal antibodies to neuronal nitric oxide synthase (nNOS) together with tumor necrosis factor alpha (TNF-α) antibodies and a potent antioxidant H-290/51 to induce neuroprotection in spinal cord injury associated with silica nanoparticles intoxication. Our results for the first time show that co-administration of nanowired delivery of antibodies to nNOS and TNF-α with H-290/51 significantly attenuated silica nanoparticles-induced exacerbation of spinal cord pathology, not reported earlier.
Keywords: Al Eskan disease; Blood–spinal cord barrier; H-290/51; Neuronal nitric synthase; Neuroprotection; Sand storm pneumonitis; Silica nanoparticles; Spinal cord edema; Spinal cord injury; Tumor necrosis factor alpha.
© 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Spinal cord injury induced exacerbation of Alzheimer's disease like pathophysiology is reduced by topical application of nanowired cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor necrosis factor alpha.Int Rev Neurobiol. 2023;172:3-35. doi: 10.1016/bs.irn.2023.05.011. Epub 2023 Sep 26. Int Rev Neurobiol. 2023. PMID: 37833015
-
A combination of tumor necrosis factor-alpha and neuronal nitric oxide synthase antibodies applied topically over the traumatized spinal cord enhances neuroprotection and functional recovery in the rat.Ann N Y Acad Sci. 2010 Jun;1199:175-85. doi: 10.1111/j.1749-6632.2009.05327.x. Ann N Y Acad Sci. 2010. PMID: 20633123
-
Histaminergic Receptors Modulate Spinal Cord Injury-Induced Neuronal Nitric Oxide Synthase Upregulation and Cord Pathology: New Roles of Nanowired Drug Delivery for Neuroprotection.Int Rev Neurobiol. 2017;137:65-98. doi: 10.1016/bs.irn.2017.09.001. Epub 2017 Nov 3. Int Rev Neurobiol. 2017. PMID: 29132544
-
Nanowired delivery of antibodies to tau and neuronal nitric oxide synthase together with cerebrolysin attenuates traumatic brain injury induced exacerbation of brain pathology in Parkinson's disease.Int Rev Neurobiol. 2023;171:83-121. doi: 10.1016/bs.irn.2023.07.001. Epub 2023 Sep 15. Int Rev Neurobiol. 2023. PMID: 37783564 Review.
-
Neuroprotective Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells and Monoclonal Antibodies to Neuronal Nitric Oxide Synthase in Brain Pathology Following Alzheimer's Disease Exacerbated by Concussive Head Injury.Adv Neurobiol. 2023;32:139-192. doi: 10.1007/978-3-031-32997-5_4. Adv Neurobiol. 2023. PMID: 37480461 Review.
References
-
- Leung CC, Yu IT, Chen W. Silicosis. Lancet. 2012;379(9830):2008–18. https://doi.org/10.1016/S0140-6736(12)60235-9 . Epub 2012 Apr 24. - DOI - PubMed
-
- Requena-Mullor M, Alarcón-Rodríguez R, Parrón-Carreño T, Martínez-López JJ, Lozano-Paniagua D, Hernández AF. Association between crystalline silica dust exposure and silicosis development in artificial stone workers. Int J Environ Res Public Health. 2021;18(11):5625. https://doi.org/10.3390/ijerph18115625 . - DOI - PubMed - PMC
-
- Pollard KM. Silica, silicosis, and autoimmunity. Front Immunol. 2016;7:97. https://doi.org/10.3389/fimmu.2016.00097 . eCollection 2016. - DOI - PubMed - PMC
-
- Kang W, Kim D, Kim MY, Kim B, Shin J, Kim EY, Choi S, Cha W, Choi BS. Usual interstitial pneumonia associated with crystalline silica exposure in pneumoconiosis: a retrospective cohort study. J Occup Environ Med. 2021;63(12):e905–10. https://doi.org/10.1097/JOM.0000000000002399 . - DOI - PubMed
-
- Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect. 1999;107(Suppl 5):793–802. https://doi.org/10.1289/ehp.99107s5793 . - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical